Treatment of Diabetic Macular Edema: An editorial
Chandra kumar
Abstract
Diabetic macular edema (DME) is the most frequent cause of vision loss in patients with diabetes and is an important public health problem. Recent randomized clinical trials have shown anti-vascular endothelial growth factor (VEGF) therapy improved visual acuity and macular swelling
Keywords: anti-vascular, corticosteroids
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 1644
- [From(publication date): 0-2020 - Jul 16, 2025]
- Breakdown by view type
- HTML page views: 877
- PDF downloads: 767